Literature DB >> 26809770

Inclusion of cytological features in tumor grading improves prognostic stratification of patients with colorectal cancer.

Annika Resch1, Lars Harbaum2, Marion J Pollheimer1, Peter Kornprat3, Richard A Lindtner4, Cord Langner5.   

Abstract

PURPOSE: Tumor grade is a traditional prognostic parameter in colorectal cancer. Remarkably, however, there is still no generally accepted consensus how to perform tumor grading. In this study, we systematically compared the prognostic value of traditional grading based upon histological features, that is, gland formation alone with grading based upon both histological and cytological features, such as nuclear pleomorphism and anaplasia ("alternative grade").
METHODS: Three hundred eighty-one tumors of randomly selected patients were retrospectively reviewed. Traditional and alternative tumor grades were related to various clinicopathological features and to progression-free and cancer-specific survival applying both univariate and multivariate testing.
RESULTS: Traditional and alternative tumor grades were significantly associated with T and N classification, tumor size, lymphovascular invasion, as well as both progression-free and cancer-specific survival. In Cox's proportional hazards regression models, the alternative grade was superior to the traditional tumor grade and was significantly associated with progression-free survival (hazard ratio 1.57, 95% confidence interval 1.04-2.35; p = 0.031), independent of patients' age and gender, T and N classification, and lymphovascular invasion. Likewise, patients with tumors with high alternative grade were more likely to die of disease (hazard ratio 1.30, 95% confidence interval 0.85-2.00), but this difference was not statistically significant (p = 0.22).
CONCLUSIONS: Tumor grade based upon both histological and cytological features was superior to grade based upon histological features alone and proved to be an independent prognostic parameter. Thus, tumor grade based upon both histological and cytological features may help to improve prognostic stratification and may thereby affect clinical decision-making and patient management.

Entities:  

Keywords:  Cancer-specific survival; Colorectal cancer; Histology; Progression-free survival; Tumor grade

Mesh:

Year:  2016        PMID: 26809770     DOI: 10.1007/s00384-015-2495-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  14 in total

1.  Is histologic grading of colon carcinoma a valid procedure?

Authors:  R E QUALHEIM; E A GALL
Journal:  AMA Arch Pathol       Date:  1953-11

2.  THE GRADING AND PROGNOSIS OF CARCINOMA OF THE COLON AND RECTUM.

Authors:  R S Grinnell
Journal:  Ann Surg       Date:  1939-04       Impact factor: 12.969

Review 3.  Challenges in the management of stage II colon cancer.

Authors:  Efrat Dotan; Steven J Cohen
Journal:  Semin Oncol       Date:  2011-08       Impact factor: 4.929

4.  European cancer mortality predictions for the year 2014.

Authors:  M Malvezzi; P Bertuccio; F Levi; C La Vecchia; E Negri
Journal:  Ann Oncol       Date:  2014-04-23       Impact factor: 32.976

Review 5.  Prognostic biomarkers in colorectal cancer: where do we stand?

Authors:  Xavier Sagaert
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

6.  The reliability of routine pathologic diagnosis of colorectal adenocarcinoma.

Authors:  J Vobecky; C P Leduc; G Devroede; P Madarnas
Journal:  Cancer       Date:  1989-09-15       Impact factor: 6.860

7.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; P J Goodman; J S Ungerleider; W A Emerson; D C Tormey; J H Glick
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

8.  Observer variation in the histological grading of rectal carcinoma.

Authors:  G D Thomas; M F Dixon; N C Smeeton; N S Williams
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

9.  Interobserver agreement in grading of colorectal cancers-findings from a nationwide web-based survey of histopathologists.

Authors:  I Chandler; R S Houlston
Journal:  Histopathology       Date:  2008-03       Impact factor: 5.087

Review 10.  Colorectal cancer.

Authors:  Hermann Brenner; Matthias Kloor; Christian Peter Pox
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321

View more
  3 in total

1.  Protein kinase C zeta suppresses low- or high-grade colorectal cancer (CRC) phenotypes by interphase centrosome anchoring.

Authors:  Ravi Kiran Deevi; Arman Javadi; Jane McClements; Jekaterina Vohhodina; Kienan Savage; Maurice Bernard Loughrey; Emma Evergren; Frederick Charles Campbell
Journal:  J Pathol       Date:  2018-03-09       Impact factor: 7.996

Review 2.  Mechanistic Insights into Colorectal Cancer Phenomics from Fundamental and Organotypic Model Studies.

Authors:  Frederick C Campbell; Maurice Bernard Loughrey; Jane McClements; Ravi Kiran Deevi; Arman Javadi; Lisa Rainey
Journal:  Am J Pathol       Date:  2018-07-18       Impact factor: 4.307

3.  The Impact of Lymphovascular Space Invasion on Recurrence and Survival in Iranian Patients With Early Stage Endometrial Cancer.

Authors:  Setareh Akhavan; Azar Ahmadzadeh; Azamsadat Mousavi; Mitra Modares Gilany; Zohreh Kazemi; Fakher Rahim; Elham Shirali
Journal:  World J Oncol       Date:  2016-09-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.